From biopharmaceuticals to medical devices, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer and more productive lives.
We have been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations. Our team of over 80 distinguished scientific, medical, investment and other professionals manages over $13 billion across public and private company investments worldwide.
The global healthcare industry sits at the intersection of several powerful long-term growth trends led by global demographics and the ineluctable advance of scientific innovation in treating disease. These trends have caused a steady increase in the level of healthcare spending in the industrialized world, led by the U.S. which now spends over 17% of its GDP on healthcare. The healthcare industry’s powerful growth profile coupled with its magnitude and complexity create myriad investment opportunities.